摘要
目的：探究肺栓塞患者采用尿激酶治疗的效果。方法选取2013年6月～2014年8月收治的35例肺栓塞患者进行治疗，随机分组，实验组19例患者选择尿激酶的治疗，对照组16例患者采用低分子肝素的治疗，对比患者治疗后的身体情况。结果实验组患者治疗有效率为94.74%，对照组患者治疗有效率为81.25%。两组患者的治疗效果差异显著，有统计学意义（P〈0.05）。结论肺栓塞患者选择尿激酶的治疗，可促使动脉的血气水平、纤溶系统得到改善，缓解其呼吸困难等增长，提高生活质量。
Objective Urokinase efficacy in treatment of pulmonary embolism is to be investigated. Methods Choose 35 pulmonary embolism patients who are treated in hospital from June 2013 to August 2014 and separate them into two groups at random;19 patients in study group are given urokinase treatment;while 16 patients in control group are given low molecular heparin treatment,and then compare treatment efficacy of these two groups. Results Treatment efficacy in study group is up to 94.74%,while treatment efficacy in control group is 81.25%,there is differential between study group and control group and such a differential has statistic value（P〈0.05）. Conclusion Applying urokinase in treatment of pulmonary embolism is conducive to improving patients’artery blood and fibrinolytic system and preventing from degeneration of breathing difficulty,which is significant to improve patients’quality of life.
出处
《中国卫生标准管理》
2015年第9期258-259,共2页
China Health Standard Management
关键词
肺栓塞
尿激酶
治疗效果
Pulmonary Embolism
Urokinase
Treatment efficacy
